Results 3,201-3,220 of 3,998 for speaker:Michael Harty

Leaders' Questions (1 Jun 2017)

Michael Harty: The strength of the reform programme is that it challenges everybody to engage in cultural change. It challenges the Government, the Department of Health, the HSE, doctors, nurses, hospital and clinical management. It demands a lot from people, but it also promises fairness and equality. We must have a health service of which we are proud and people will not be afraid. It will not be...

Nursing Homes Support Scheme: Motion [Private Members] (31 May 2017)

Michael Harty: I move:That Dáil Éireann: recognises:— the importance of the Nursing Homes Support Scheme, which provides essential financial support for those in need of long-term nursing home care; — that the participants of the Nursing Homes Support Scheme contribute to the cost of their care according to their income and assets, and that this contribution can be considerable...

Joint Oireachtas Committee on Health: Business of Committee (31 May 2017)

Michael Harty: We will now go into private session.

Joint Oireachtas Committee on Health: National Cancer Registry Board: Chairperson Designate (31 May 2017)

Michael Harty: The purpose of this part of this afternoon's meeting is to engage with the chairperson designate of the National Cancer Registry Board, NCRB, Dr. Jerome Coffey, in order to discuss his strategic priorities for the role and his views on the challenges currently facing the board. The committee welcomes the opportunity to meet with Dr. Coffey and hear his views. On behalf of the committee, I...

Joint Oireachtas Committee on Health: National Cancer Registry Board: Chairperson Designate (31 May 2017)

Michael Harty: I thank Dr. Coffey and will open the discussion to the floor if members have gathered their thoughts.

Joint Oireachtas Committee on Health: National Cancer Registry Board: Chairperson Designate (31 May 2017)

Michael Harty: Yesterday, the Committee on the Future of Healthcare report was launched. It is a comprehensive report looking at a ten-year vision for the health service rather than going from year to year and trying to move from our two-tier system to a single-tier model. Does Dr. Coffey see the removal of private care in public hospitals as a positive or a negative in the treatment of cancer? As a...

Joint Oireachtas Committee on Health: National Cancer Registry Board: Chairperson Designate (31 May 2017)

Michael Harty: Built into our report is a large section on e-health and the exchange and gathering of data. Obviously, data is king and the more data we have, the better we can plan our health services. I hope the hospitals would be returning data to the registry rather than it being a case of the registry having to go out and look for it.

Joint Oireachtas Committee on Health: National Cancer Registry Board: Chairperson Designate (31 May 2017)

Michael Harty: In my experience of referring patients on, I always recommend people go to the public system because all the back-up services and specialist services, the specialist nurses and ancillary services that are needed are all available. I do not want to throw any dark light on private care. However, the public system gives much more comprehensive care in respect of cancer. In respect of the...

Joint Oireachtas Committee on Health: National Cancer Registry Board: Chairperson Designate (31 May 2017)

Michael Harty: Is it called colorectal screening? That is the stool test.

Joint Oireachtas Committee on Health: National Cancer Registry Board: Chairperson Designate (31 May 2017)

Michael Harty: In respect of HPV vaccination, is there a plan to extend it to boys?

Joint Oireachtas Committee on Health: National Cancer Registry Board: Chairperson Designate (31 May 2017)

Michael Harty: Is there a cost implication?

Joint Oireachtas Committee on Health: National Cancer Registry Board: Chairperson Designate (31 May 2017)

Michael Harty: On that point, have the girls who have reported side effects as a group been studied in Ireland to see the commonality of their symptoms?

Joint Oireachtas Committee on Health: National Cancer Registry Board: Chairperson Designate (31 May 2017)

Michael Harty: Dr. Kevin Kelleher was here a number of weeks ago. In the HSE literature, there was a reference to care pathways for patients with symptoms. He said that care pathway was not specifically for girls who have identified symptoms post-vaccine. It was for the general population who may have symptoms. It appears to me that if we want to increase the vaccination rate, we really need to approach...

Joint Oireachtas Committee on Health: National Cancer Registry Board: Chairperson Designate (31 May 2017)

Michael Harty: There is a sense that they are not being taken seriously. One appreciates that there is no scientific connection, but nevertheless their worries and concerns need to be collated and respected.

Joint Oireachtas Committee on Health: National Cancer Registry Board: Chairperson Designate (31 May 2017)

Michael Harty: I thank Dr. Coffey. In his opening statement he said that the incidence of cancer will go up by 50% between 2015 and 2025 and by approximately 100% by 2040. Will he outline the factors which influence those increases?

Joint Oireachtas Committee on Health: National Cancer Registry Board: Chairperson Designate (31 May 2017)

Michael Harty: There is an advertisement running at the moment, which I believe is sponsored by the Irish Cancer Society, which suggests that one in eight cancers is related to alcohol intake. Will Dr. Coffey elaborate on that?

Joint Oireachtas Committee on Health: National Cancer Registry Board: Chairperson Designate (31 May 2017)

Michael Harty: Is alcohol associated with one in eight cancers?

Joint Oireachtas Committee on Health: National Cancer Registry Board: Chairperson Designate (31 May 2017)

Michael Harty: Does that refer to breast cancers or all cancers?

Joint Oireachtas Committee on Health: National Cancer Registry Board: Chairperson Designate (31 May 2017)

Michael Harty: I thank Dr. Coffey and wish him the best of luck in his chairmanship of the National Cancer Registry Board. We may engage with him again in the future if he is amenable to that.

Joint Oireachtas Committee on Health: National Treatment Purchase Fund: Chairperson Designate (31 May 2017)

Michael Harty: The purpose of this part of this afternoon's session is to engage with the chairperson designate of the National Treatment Purchase Fund, NTPF, Mr. John Horan, to discuss his strategic priorities for the role and his views on the challenges currently facing the NTPF. On behalf of the committee, I welcome him and thank him for coming. I wish to draw his attention to the fact that by virtue...